| Authors: |
Xu Y; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Ma L; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Norton MG; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Stuart C; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Zhao Z; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Toibero D; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Dahlen S; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Zhong L; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Zhang P; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States., Struble EB; Division of Hematology Research and Review, Office of Blood Research and Review, CBER, FDA, United States. Electronic address: evi.struble@fda.hhs.gov. |
